Stockscreener 앱 받기
23.77
1.89%
0.44
시간 외 거래:
24.55
0.78
+3.28%
전일 마감가:
$23.33
열려 있는:
$23.2
하루 거래량:
792.39K
Relative Volume:
1.75
시가총액:
$995.81M
수익:
$384.90M
순이익/손실:
$-851.00K
주가수익비율:
-1,188.50
EPS:
-0.02
순현금흐름:
$12.83M
1주 성능:
+0.17%
1개월 성능:
+2.37%
6개월 성능:
-14.77%
1년 성능:
+13.57%
1일 변동 폭
$23.14
$23.91
1주일 범위
$23.04
$24.23
52주 변동 폭
$20.98
$32.33
Artivion Inc Stock (AORT) Company Profile
명칭
Artivion Inc
전화
(770) 419-3355
주소
1655 ROBERTS BOULEVARD N W, KENNESAW
AORT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
23.77 | 995.81M | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-27 | 재확인 | Lake Street | Buy |
| 2022-08-08 | 개시 | Lake Street | Buy |
| 2022-03-03 | 개시 | Stifel | Buy |
Artivion Inc 주식(AORT)의 최신 뉴스
Artivion (AORT) Reports Q1 2025 Growth and Raises Full-Year Guid - GuruFocus
Artivion: Q1 Earnings Snapshot - MySA
Earnings call transcript: Artivion Q1 2025 revenue misses forecast, stock rises - Investing.com
Artivion Q1 2025 slides: Revenue grows 4% as cyber incident recovery accelerates - Investing.com India
Artivion’s (NYSE:AORT) Q1: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Artivion Inc (AORT) Q1 2025 Earnings: EPS of $(0.01) Beats Estimate, Revenue Surpasses Expectations at $99 Million - GuruFocus
Artivion (AORT) Raises Revenue Outlook for 2025 | AORT Stock News - GuruFocus
Artivion Reports First Quarter 2025 Financial Results | AORT Stock News - GuruFocus
Artivion Reports First Quarter 2025 Financial Results - Star Local Media
Artivion (AORT) Shares Promising Clinical Data from Nexus Triomphe Trial | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - PR Newswire
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Artivion (AORT) to Release Quarterly Earnings on Monday - Defense World
Artivion: Q4 Earnings Snapshot - Barchart.com
Artivion Inc (AORT) Q1 2025 Earnings Report Preview: What To Loo - GuruFocus
Wells Fargo & Company MN Buys 6,299 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) rises 5.3% this week, taking three-year gains to 16% - simplywall.st
LPL Financial LLC Grows Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results | AORT Stock News - GuruFocus
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results - Kilgore News Herald
JPMorgan Chase & Co. Increases Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Sold by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Buys 600 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year - Yahoo Finance
Arrowstreet Capital Limited Partnership Invests $288,000 in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Purchased by Vanguard Group Inc. - Defense World
Raymond James Financial Inc. Buys New Shares in Artivion, Inc. (NYSE:AORT) - Defense World
Strength Seen in Artivion (AORT): Can Its 7.9% Jump Turn into More Strength? - Nasdaq
Artivion, Inc. (NYSE:AORT) Shares Acquired by American Century Companies Inc. - Defense World
Here's Why Artivion (NYSE:AORT) Has A Meaningful Debt Burden - simplywall.st
KLP Kapitalforvaltning AS Makes New Investment in Artivion, Inc. (NYSE:AORT) - Defense World
Corebridge Financial Inc. Cuts Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Thrivent Financial for Lutherans Lowers Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Natixis Advisors LLC Makes New Investment in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (AORT): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Do Options Traders Know Something About Artivion (AORT) Stock We Don't? - TradingView
Artivion, Inc. (NYSE:AORT) Shares Sold by PNC Financial Services Group Inc. - Defense World
Charles Schwab Investment Management Inc. Has $10.24 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Bought by Amundi - The AM Reporter
Artivion at Oppenheimer Conference: Strategic Resilience Amid Challenges - Investing.com
Artivion, Inc. (NYSE:AORT) Shares Sold by Victory Capital Management Inc. - Defense World
Artivion, Inc. (NYSE:AORT) Shares Sold by Bank of New York Mellon Corp - Defense World
Artivion chief commercial officer John E. Davis sells $356,548 in stock - Investing.com Australia
Artivion’s SVP Jean Holloway sells $425k in stock - Investing.com India
Smartleaf Asset Management LLC Boosts Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion’s SVP Jean Holloway sells $425k in stock By Investing.com - Investing.com South Africa
Artivion chief commercial officer John E. Davis sells $356,548 in stock By Investing.com - Investing.com South Africa
Artivion’s CFO Lance Berry sells shares worth $121,763 By Investing.com - Investing.com Australia
Artivion’s SVP Marshall Stanton sells $39,761 in common stock By Investing.com - Investing.com Australia
Artivion Inc (AORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
11.62%
0.20%
자본화:
|
볼륨(24시간):